CVRx Announces Chief Financial Officer Transition
CVRx, Inc., a NASDAQ-listed medical device company specializing in neuromodulation solutions for cardiovascular diseases, announced that CFO Jared Oasheim will step down to pursue other opportunities but will stay until a successor is appointed and remain an advisor through February 2027. Oasheim has been with the company since 2015 and helped lead…